Latest Breaking News On - Adult patients with acute myeloid leukemia - Page 1 : comparemela.com

A phase 2 study found 91% complete remission in patients with AML who received venetoclax plus standard therapy. The study was published as a preprint and has not yet been peer reviewed.

Huafeng wangEntrepreneur team introduction program of zhejiangNational natural science foundation of chinaZhejiang university school of medicineEuropean leukemianetLeading innovativeEntrepreneur team introduction programNational natural science foundationFirst line therapyAdult patients with acute myeloid leukemiaZhejiang university schoolAcute leukemiaAcute myeloblastic leukemiaPhysician assistantsPeer reviewYoung adult